Physician profile
Christine E Waldron
NPI 1639262884
$1,384.85
in general payments reported to CMS, 2019-2025
23 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $175 · 2021: $57.29 · 2022: $12.64 · 2023: $216 · 2024: $269 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.76 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $244.16 | 2019-2024 | Slynd |
| Lilly USA, LLC | $127.63 | 2019-2021 | |
| Millicent US INC | $111.80 | 2024-2025 | Intrarosa |
| Mayne Pharma Commercial LLC | $83.78 | 2023-2025 | |
| Tesaro, INC. | $72.22 | 2019 | |
| Abbvie INC. | $70.44 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Medtronic Vascular, INC. | $66.82 | 2020 | |
| Tolmar, INC. | $61.40 | 2025 | Jatenzo |
| Coopersurgical, INC. | $60.24 | 2020-2024 | Sos, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $59.41 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $57.30 | 2019-2024 | Gardasil 9, Gardasil |
| Amag Pharmaceuticals, INC. | $51.85 | 2019 | |
| Biogen, INC. | $49.77 | 2025 | Zurzuvae |
| Allergan, INC. | $49.29 | 2019-2020 | |
| Novo Nordisk INC | $48.25 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $33.89 | 2024 | Cologuard Collection Kit |
| Mission Pharmacal Company | $30.06 | 2019-2020 | |
| Therapeuticsmd, INC. | $22.69 | 2019 | |
| Aspira Women'S Health INC | $20.60 | 2024 | Ova1 |
| Duchesnay USA Incorporated | $18.36 | 2019 | |
| Hologic Sales and Service, LLC | $18.30 | 2021 | |
| Covidien LP | $15.29 | 2019 | |
| Agile Therapeutics, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.